Oncology Clinical Researcher

Alignerr Corp.; Denver (CO); Remote; USD 83,000 - 165,000; Part time

Benefits offered by this job

Fully remote

Flexible schedule

Potential ongoing work contracts

Job summary

Alignerr seeks an Oncology Clinical Researcher to shape AI training with real-world oncology trial rigor. This remote, hourly contract role emphasizes trial design, data analysis, and regulatory alignment in a flexible, independent setting.

You will design protocols, analyze cancer trial outcomes, and translate findings into regulatory insights for FDA/EMA standards, ensuring AI content meets clinical quality.

Qualifications

• Experience designing and managing oncology clinical trials from protocol to data readout.
• Strong analytical skills for oncology trial data, safety monitoring and biomarker analysis.
• Familiarity with regulatory submission standards (FDA/EMA).

Responsibilities

• Design and evaluate oncology trial protocols, including study design and enrollment criteria.
• Analyze trial data for safety, efficacy endpoints, and biomarkers.
• Translate trial outcomes into regulatory and scientific insights aligned with agency standards.
• Review AI-generated clinical content for accuracy, relevance, and regulatory alignment.
• Ensure AI systems reflect real-world oncology standards in reasoning.

Skills

Oncology trial design

Data analysis

Regulatory standards

Remote work

Job description

Oncology Clinical Researcher (AI Training)

About The Role

What if your deep expertise in cancer clinical trials could directly shape how AI understands and reasons about oncology — influencing research that affects patients worldwide? We're looking for Oncology Clinical Researchers to bring real-world clinical rigor into cutting-edge AI training and evaluation workflows. This is a fully remote, flexible contract role. You don't need an AI background — just a strong foundation in oncology trial design, data analysis, and regulatory standards.

• Organization: Alignerr
• Type: Hourly Contract
• Location: Remote
• Commitment: 10–40 hours/week

What You'll Do

• Design and evaluate oncology clinical trial protocols, including study design, patient enrollment criteria, and regulatory compliance standards
• Analyze cancer trial data — covering safety profiles, efficacy endpoints, and biomarker results — to assess treatment performance and clinical validity
• Translate trial outcomes into clear regulatory and scientific insights aligned with FDA, EMA, and other agency standards
• Review and critique AI-generated clinical content for scientific accuracy, clinical relevance, and regulatory alignment
• Help ensure that AI systems reasoning about oncology data reflect real-world standards and best practices

Who You Are

• Experienced in designing and managing oncology clinical trials — from protocol development through data readout
• Strong analytical background in oncology clinical data, including efficacy endpoints, safety monitoring, and biomarker analysis
• Familiar with regulatory submission standards for major agencies such as the FDA or EMA
• Detail-oriented and rigorous — you hold AI-generated outputs to the same standard you'd apply to a real trial report
• Self-motivated and comfortable working independently in an asynchronous, remote environment

Nice to Have

• Prior experience with data annotation, data quality assurance, or AI evaluation systems
• Background in oncology subspecialties such as hematology, solid tumors, or immuno-oncology
• Experience contributing to publications, regulatory submissions, or clinical decision-support tools
• Familiarity with AI tools or clinical data platforms as an end user

Why Join Us

• Work directly on frontier AI systems being built to transform cancer research and clinical decision-making
• Influence how AI models understand, evaluate, and reason about real oncology trial data
• Fully remote and flexible — work when and where it suits you
• Freelance autonomy with the structure of meaningful, high-impact work
• Collaborate with world-leading AI research teams and labs
• Potential for ongoing work and contract extension as new projects launch